The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[4-[[3,5-dimethyl-6-[4-(1H-pyrazolo[4,3-c]pyridin-7-yl)piperazine-1-carbonyl]-2-pyridyl]amino]-1-piperidyl]benzonitrile ID: ALA5221046
PubChem CID: 168298767
Max Phase: Preclinical
Molecular Formula: C30H33N9O
Molecular Weight: 535.66
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C)c(C(=O)N2CCN(c3cncc4cn[nH]c34)CC2)nc1NC1CCN(c2ccccc2C#N)CC1
Standard InChI: InChI=1S/C30H33N9O/c1-20-15-21(2)29(34-24-7-9-37(10-8-24)25-6-4-3-5-22(25)16-31)35-27(20)30(40)39-13-11-38(12-14-39)26-19-32-17-23-18-33-36-28(23)26/h3-6,15,17-19,24H,7-14H2,1-2H3,(H,33,36)(H,34,35)
Standard InChI Key: YLDJDXDYJDCIEK-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 45 0 0 0 0 0 0 0 0999 V2000
-0.3829 -0.6830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3419 -1.0769 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0454 -0.6461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0241 0.1786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2992 0.5724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4043 0.1416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7703 -1.0400 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0865 -1.1138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8114 -0.7200 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8327 0.1047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5576 0.4985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2612 0.0676 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9861 0.4615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0074 1.2863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7323 1.6802 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.4359 1.2493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4145 0.4246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6896 0.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2398 -0.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5149 -1.1508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0651 -1.9386 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7388 0.5912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1189 0.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1988 -1.0031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9024 -0.5724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3095 0.2891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0131 0.7199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9919 1.5446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2670 1.9386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5634 1.5077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5847 0.6830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8811 0.2522 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1563 0.6462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4526 0.2154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4739 -0.6092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3095 -0.5360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3095 -1.3613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.0131 -0.1429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8403 -0.7803 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.6582 -0.8877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
6 1 2 0
5 6 1 0
3 7 1 0
1 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
18 13 2 0
17 18 1 0
12 19 1 0
20 9 1 0
19 20 1 0
8 21 2 0
4 22 1 0
6 23 1 0
25 24 1 0
27 26 1 0
28 27 2 0
29 28 1 0
30 29 2 0
31 30 1 0
26 31 2 0
32 31 1 0
32 25 1 0
33 32 1 0
34 33 1 0
35 34 1 0
24 35 1 0
7 35 1 0
26 36 1 0
36 37 3 0
17 38 1 0
18 39 1 0
39 40 1 0
40 38 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 535.66Molecular Weight (Monoisotopic): 535.2808AlogP: 3.88#Rotatable Bonds: 5Polar Surface Area: 117.07Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.64CX Basic pKa: 6.01CX LogP: 3.15CX LogD: 3.13Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.40Np Likeness Score: -1.53
References 1. Oleksak P, Nepovimova E, Chrienova Z, Musilek K, Patocka J, Kuca K.. (2022) Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021)., 238 [PMID:35688004 ] [10.1016/j.ejmech.2022.114498 ]